Kolinsky Wealth Management LLC Sells 282 Shares of Danaher Co. (NYSE:DHR)

by · The Markets Daily

https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/danaher-co-logo.png?v=20210524093152
Kolinsky Wealth Management LLC reduced its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 23.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 942 shares of the conglomerate’s stock after selling 282 shares during the period. Kolinsky Wealth Management LLC’s holdings in Danaher were worth $224,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of DHR. Bank Julius Baer & Co. Ltd Zurich raised its position in Danaher by 100,144.5% during the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,184,308,095 shares of the conglomerate’s stock worth $284,233,943,000 after purchasing an additional 1,183,126,676 shares during the last quarter. Moneta Group Investment Advisors LLC grew its holdings in Danaher by 96,490.5% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s stock worth $6,180,839,000 after acquiring an additional 23,262,904 shares during the period. Norges Bank acquired a new stake in Danaher during the 4th quarter worth about $2,057,164,000. JPMorgan Chase & Co. grew its holdings in Danaher by 66.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 5,997,282 shares of the conglomerate’s stock worth $1,439,348,000 after acquiring an additional 2,398,426 shares during the period. Finally, Capital International Investors grew its holdings in Danaher by 20.4% during the 2nd quarter. Capital International Investors now owns 14,029,348 shares of the conglomerate’s stock worth $3,366,677,000 after acquiring an additional 2,377,625 shares during the period. 76.71% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of NYSE DHR opened at $217.49 on Friday. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $249.59. The stock has a market cap of $160.71 billion, a price-to-earnings ratio of 27.43, a PEG ratio of 2.20 and a beta of 0.84. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.94 and a current ratio of 2.26. The firm’s 50-day simple moving average is $208.65 and its 200 day simple moving average is $233.47.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Tuesday, October 24th. The conglomerate reported $2.02 earnings per share for the quarter, beating the consensus estimate of $1.83 by $0.19. Danaher had a net margin of 20.01% and a return on equity of 13.71%. The business had revenue of $6.87 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter last year, the firm earned $2.56 EPS. The firm’s revenue for the quarter was down 10.3% compared to the same quarter last year. As a group, research analysts anticipate that Danaher Co. will post 8.3 earnings per share for the current fiscal year.

Danaher Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be given a dividend of $0.24 per share. The ex-dividend date is Thursday, December 28th. This represents a $0.96 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio is currently 13.62%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. StockNews.com assumed coverage on Danaher in a report on Saturday. They set a “hold” rating for the company. The Goldman Sachs Group downgraded Danaher from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $215.00 to $205.00 in a report on Thursday. Raymond James reduced their target price on Danaher from $250.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, October 25th. Citigroup reduced their target price on Danaher from $265.92 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Finally, Wells Fargo & Company reduced their target price on Danaher from $285.00 to $247.00 and set an “overweight” rating for the company in a research note on Tuesday, October 3rd. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $257.07.

Check Out Our Latest Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

Featured Articles